Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5332071

C=C(C)C(=O)NC(CC)[N+](C)(C)CC(=O)OCC.[Cl-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
TGFBR1 P36897 1/20 0.34
THRB P10828 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
TRPA1 O75762 1/20 0.30
ALDH1A1 P00352 1/20 0.30
POLB P06746 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2124453 0.88 TGFBR1 (0.36) TGFBR1
SCHEMBL9451823 0.78 TGFBR1 (0.42) TGFBR1ALDH1A1
Fluoride Ion SCHEMBL8934072 0.77 TGFBR1 (0.41) TGFBR1
Hydrochloric Acid SCHEMBL4764541 0.76 TGFBR1 (0.43) TGFBR1ALDH1A1
Hydrochloric Acid SCHEMBL61003 0.76 TGFBR1 (0.43) TGFBR1ALDH1A1
Hydrochloric Acid SCHEMBL4920381 0.75 TGFBR1 (0.42) TGFBR1ALDH1A1
SCHEMBL33606 0.74 TGFBR1 (0.44) TGFBR1ALDH1A1
SCHEMBL12027706 0.74 TGFBR1 (0.34) TGFBR1
Hydrochloric Acid SCHEMBL10425311 0.74 TGFBR1 (0.39) TGFBR1
Hydrochloric Acid SCHEMBL10337216 0.74 TGFBR1 (0.42) TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539676-B1 MONOMER COMPOUND COMPRISING SEVERAL CATIONIC GROUPS, PROCESS FOR MAKING THE SAME, AND POLYMERS COMPRISING UNITS DERIVING THEREFROM SOLVAY USA INC (US) 2017-07-26 EP disclosed
EP-2644592-A1 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom RHODIA INC. (US) 2013-10-02 EP disclosed
US-7247693-B2 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom RHODIA INC. (US) 2007-07-24 US disclosed
EP-1539676-A4 MONOMER COMPOUND COMPRISING SEVERAL CATIONIC GROUPS, PROCESS FOR MAKING THE SAME, AND POLYMERS COMPRISING UNITS DERIVING THEREFROM RHODIA (US) 2007-02-21 EP disclosed
US-20060111533-A1 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom RHODIA OPERATIONS (FR) 2006-05-25 US disclosed
US-7030275-B2 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom RHODIA INC. (US) 2006-04-18 US disclosed
EP-1539676-A1 MONOMER COMPOUND COMPRISING SEVERAL CATIONIC GROUPS, PROCESS FOR MAKING THE SAME, AND POLYMERS COMPRISING UNITS DERIVING THEREFROM Rhodia Inc. (US) 2005-06-15 EP disclosed
US-20040010106-A1 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom RHODIA OPERATIONS (FR) 2004-01-15 US disclosed
WO-2003101935-A1 MONOMER COMPOUND COMPRISING SEVERAL CATIONIC GROUPS, PROCESS FOR MAKING THE SAME, AND POLYMERS COMPRISING UNITS DERIVING THEREFROM RHODIA INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040010106-A1 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom PCNA, PBRM1, B2M MGAM 1696/4885GAA 4211/4885SI 3205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.